GENERAL ASSEMBLY OF NORTH CAROLINA

1987 SESSION

 

 

CHAPTER 412

HOUSE BILL 878

 

AN ACT TO MAKE CHANGES IN THE SCHEDULING OF CERTAIN CONTROLLED SUBSTANCES.

 

The General Assembly of North Carolina enacts:

 

Section 1.  G.S. 90-89(a) is amended by adding new sub-subdivisions in the proper alphabetical order to read:

"28a.        1-methyl-4-phenyl-4-propionoxypiperidine (MPPP).

"28b.        3-Methylfentanyl (N-[3-methyl-1-(2-Phenylethyl)-4-Piperidyl]-N-Phenylpropanamide).

"35a.        1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine (PEPAP)."

Sec. 2.  G.S. 90-89(a) is amended by deleting the following sub-subdivision:

"1a.      Alfentanil."

Sec. 3.  G.S. 90-89(b) is amended by rewriting the following sub-subdivision to read:

"13.  Methyldihydromorphine."

Sec. 4.  G.S. 90-89(c) is amended by adding a new sub-subdivision in the proper alphabetical order to read:

"2a.      3,4-Methylenedioxymethamphetamine (MDMA).

Sec. 5.  G.S. 90-89(e) is amended by adding a new sub-subdivision in the proper alphabetical order to read:

"2.        N-ethylamphetamine."

Sec. 5A.  G.S. 90-90(a)(1) is amended by inserting between the phrase "nalbuphine," and the word "naloxone" the phrase "dextrorphan," and is further amended by deleting "and naltrexone" and inserting in lieu thereof the phrase "naltrexone, and nalmefene".

Sec. 6.  G.S. 90-90(b) is amended by adding a new sub-subdivision in the proper alphabetical order to read:

"01.     Alfentanil."

Sec. 7.  G.S. 90-90 is amended by adding a new subsection to read:

"(e)      Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, including their salts, isomers, and salts of isomers, unless specifically excepted, or listed in another schedule, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

"1.  Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product.  [Some other names: (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-o1, or (-)-delta-9-(trans)-tetrahydrocannabinol]."

Sec. 8.  G.S. 90-91(b) is amended by adding a new sub-subdivision in the proper alphabetical order to read:

"9a.      Tiletamine and zolazepam or any salt thereof.  Some trade or other names for tiletamine-zolazepam combination product: Telazol.  Some trade or other names for tiletamine:

2-(ethylamino)-2-(2-thienyl)-cyclohexanone.  Some trade or other names for zolazepam:  4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e][1,4]-diazepin-7(1H)-one. flupyrazapon."

Sec. 9.  G.S. 90-91(j) is amended by rewriting the following sub-subdivision to read:

"3.  Clortermine."

Sec. 10.  G.S. 90-91(j) is amended by deleting the following sub-subdivision:

"4.  Mazindol."

Sec. 11. G.S. 90-92(a) is amended by rewriting the sub-subdivisions to read:

"1.   Alprazolam.

"2.   Barbital.

"3.   Bromazepam.

"4.   Camazepam.

"5.   Chloral betaine.

"6.   Chloral hydrate.

"7.   Chlordiazepoxide.

"8.   Clobazam.

"9.   Clonazepam.

"10.  Clorazepate.

"11.  Clotiazepam.

"12.  Cloxazolam.

"13.  Delorazepam.

"14.  Diazepam.

"15.  Estazolam.

"16.  Ethchlorvynol.

"17.  Ethinamate.

"18.  Ethyl loflazepate.

"19.  Fludiazepam.

"20.  Flunitrazepam.

"21.  Flurazepam.

"22.  Halazepam.

"23.  Haloxazolam.

"24.  Ketazolam.

"25.  Loprazolam.

"26.  Lorazepam.

"27.  Lormetazepam.

"28.  Mebutamate.

"29.  Medazepam.

"30.  Meprobamate.

"31.  Methohexital.

"32.  Methylphenobarbital (mephobarbital).

"33.  Midazolam.

"34.  Nimetazepam.

"35.  Nitrazepam.

"36.  Nordiazepam.

"37.  Oxazepam.

"38.  Oxazolam.

"39.  Paraldehyde.

"40.  Petrichloral.

"41.  Phenobarbital.

"42.  Pinazepam.

"43.  Prazepam.

"44.  Quazepam.

"45.  Temazepam.

"46.  Tetrazepam.

"47.  Triazolam."

Sec. 12.  G.S. 90-92(f) is amended by adding a new subdivision to read:

 "2.  Buprenorphine."

Sec. 13.  G.S. 90-101 is amended by adding a new subsection to read:

"(i)       A physician licensed by the Board of Medical Examiners pursuant to Article 1 of this Chapter may dispense or administer Dronabinol as scheduled in G.S. 90-90(e) only as an antiemetic agent in cancer chemotherapy."

Sec. 14.  This act is effective upon ratification.

In the General Assembly read three times and ratified this the 18th day of June, 1987.